Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Journal of Cellular Physiology|June 17, 2011
Strong expression association between matriptase and its substrate prostasin in breast cancerChristopher Bergum, Gina Zoratti, Julie Boerner, et al.Biological Chemistry|March 17, 2025
GPI-anchored serine proteases: essential roles in development, homeostasis, and diseaseJoseph G Lundgren, Michael G Flynn, Karin ListThe American Journal of Pathology|April 25, 2009
Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethalityRoman Szabo, Peter Kosa, Karin List, et al.The Biochemical Journal|January 22, 2003
The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activationNiels Behrendt, Karin List, Peter A Andreasen, et al.Journal of Cellular Physiology|May 2, 2007
Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptaseKarin List, John P Hobson, Alfredo Molinolo, et al.The American Journal of Pathology|May 3, 2006
Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesisKarin List, Roman Szabo, Alfredo Molinolo, et al.Development (Cambridge, England)|July 14, 2009
Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in miceRoman Szabo, John P Hobson, Kristina Christoph, et al.The Journal of Biological Chemistry|October 3, 2003
The low density lipoprotein receptor-related protein modulates protease activity in the brain by mediating the cellular internalization of both neuroserpin and neuroserpin-tissue-type plasminogen activator complexesAlexandra Makarova, Irina Mikhailenko, Thomas H Bugge, et al.The Journal of Biological Chemistry|August 21, 2008
Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activityRoman Szabo, John P Hobson, Karin List, et al.Breast Cancer Research : BCR|July 14, 2012
Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of MetKelly L Mueller, Julie M Madden, Gina L Zoratti, et al.Pageof 6